Patents by Inventor Young-Ae Yoon
Young-Ae Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240176641Abstract: An apparatus and method for executing a digital twin is provided. The apparatus includes a generation module configured to generate first to Nth digital twin Docker images by combining first to Nth digital twin models, where assets are virtualized, and first to Nth Docker images, respectively, wherein each of the digital twin Docker images includes the corresponding digital twin model and a file required for executing the corresponding digital twin model (N being a natural number greater than 1), an authoring module configured to author a digital twin workflow by connecting the first to Nth digital twin Docker images, a scheduling module configured to select a target digital twin Docker image to be currently executed from the digital twin workflow, and schedule execution of the selected target digital twin Docker image, and an execution module configured to execute the target digital twin Docker image according to the scheduling result.Type: ApplicationFiled: September 11, 2023Publication date: May 30, 2024Inventors: Seung Woog JUNG, Hyun Chul KANG, Min Gi KIM, Ji Yeon SON, Young Seog YOON, Yong Kwi LEE, Eun Seo LEE, Hark Jin LEE, Young Ae CHUN
-
Patent number: 11981658Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.Type: GrantFiled: August 26, 2022Date of Patent: May 14, 2024Assignees: Yuhan Corporation, Janssen Biotech, Inc.Inventors: Byoungmoon Lee, Hyunjoo Lee, Gyu Jin Lee, Su Bin Choi, Sol Park, Heejun Kim, Misong Kim, Young Ae Yoon, Kwan Hoon Hyun, Tae Kyun Kim, Jae Young Sim, Marian C. Bryan, Scott Kuduk, James Campbell Robertson
-
Publication number: 20240152130Abstract: Disclosed are an apparatus for configuring an equipment behavior catalog (EBC) and a virtual production system using an EBC. The apparatus for configuring the EBC according to an aspect of the present invention includes an artificial intelligence model storage configured to store an artificial intelligence model, and an EBC storage configured to store an EBC including artificial intelligence model data for the artificial intelligence model stored in the artificial intelligence model storage.Type: ApplicationFiled: November 7, 2023Publication date: May 9, 2024Inventors: Young Ae CHUN, Ho Jin PARK, Hark Jin LEE, Ji Yeon SON, Young Seog YOON, Eun Seo LEE, Seung Woog JUNG
-
Patent number: 11945798Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.Type: GrantFiled: August 26, 2022Date of Patent: April 2, 2024Assignees: YUHAN CORPORATION, JANSSEN BIOTECH, INC.Inventors: Hyunjoo Lee, Su Bin Choi, Young Ae Yoon, Kwan Hoon Hyun, Jae Young Sim, Marian C. Bryan, Scott Kuduk, James Campbell Robertson, Jaekyoo Lee, Paresh Devidas Salgaonkar, Byung-Chul Suh, Jong Sung Koh, So Young Hwang
-
Publication number: 20230085912Abstract: Provided are 5-membered heteroaryl-containing aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.Type: ApplicationFiled: August 26, 2022Publication date: March 23, 2023Applicants: YUHAN CORPORATION, JANSSEN BIOTECH, INC.Inventors: Byoungmoon LEE, Hyunjoo LEE, Gyu Jin LEE, Su Bin CHOI, Misong KIM, Young Ae YOON, Kwan Hoon HYUN, Jae Young SIM, Marian C. BRYAN, Scott KUDUK, James Campbell ROBERTSON, Jaekyoo LEE, Paresh Devidas SALGAONKAR, Byung-Chul SUH, Jong Sung KOH, So Young HWANG
-
Publication number: 20230086884Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.Type: ApplicationFiled: August 26, 2022Publication date: March 23, 2023Applicants: YUHAN CORPORATION, JANSSEN BIOTECH, INC.Inventors: Byoungmoon LEE, Hyunjoo LEE, Gyu Jin LEE, Su Bin CHOI, Sol PARK, Heejun KIM, Misong KIM, Young Ae YOON, Kwan Hoon HYUN, Tae Kyun KIM, Jae Young SIM, Marian C. BRYAN, Scott KUDUK, James Campbell ROBERTSON
-
Publication number: 20230086795Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.Type: ApplicationFiled: August 26, 2022Publication date: March 23, 2023Applicants: YUHAN CORPORATION, JANSSEN BIOTECH, INC.Inventors: Hyunjoo LEE, Su Bin CHOI, Young Ae YOON, Kwan Hoon HYUN, Jae Young SIM, Marian C. BRYAN, Scott KUDUK, James Campbell Robertson, Jaekyoo LEE, Paresh Devidas SALGAONKAR, Byung-Chul SUH, Jong Sung KOH, So Young HWANG
-
Publication number: 20230090406Abstract: Provided are 6-membered heteroaryl-containing aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.Type: ApplicationFiled: August 26, 2022Publication date: March 23, 2023Applicants: YUHAN CORPORATION, JANSSEN BIOTECH, INC.Inventors: Hyunjoo LEE, Su Bin CHOI, Misong KIM, Young Ae YOON, Kwan Hoon HYUN, Jae Young SIM
-
Patent number: 10640490Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: GrantFiled: November 15, 2017Date of Patent: May 5, 2020Assignee: Yuhan CorporationInventors: Hyun-Joo Lee, Dong-Hoon Kim, Tae-Kyun Kim, Young-Ae Yoon, Jae-Young Sim, Myung-Hun Cha, Eun-Jung Jung, Kyoung-Kyu Ahn, Tai-Au Lee
-
Patent number: 10227330Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: GrantFiled: December 20, 2017Date of Patent: March 12, 2019Assignee: YUHAN CORPORATIONInventors: Hyun-Joo Lee, Dong-Hoon Kim, Tae-Kyun Kim, Young-Ae Yoon, Jae-Young Sim, Myung-Hun Cha, Eun-Jung Jung, Kyoung-Kyu Ahn, Tai-Au Lee
-
Publication number: 20180111918Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: ApplicationFiled: December 20, 2017Publication date: April 26, 2018Applicant: YUHAN CORPORATIONInventors: Hyun-Joo LEE, Dong-Hoon KIM, Tae-Kyun KIM, Young-Ae YOON, Jae-Young SIM, Myung-Hun CHA, Eun-Jung JUNG, Kyoung-Kyu AHN, Tai-Au LEE
-
Publication number: 20180072705Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: ApplicationFiled: November 15, 2017Publication date: March 15, 2018Applicant: Yuhan CorporationInventors: Hyun-Joo LEE, Dong-Hoon KIM, Tae-Kyun KIM, Young-Ae YOON, Jae-Young SIM, Myung-Hun CHA, Eun-Jung JUNG, Kyoung-Kyu AHN, Tai-Au LEE
-
Patent number: 9890138Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: GrantFiled: February 24, 2012Date of Patent: February 13, 2018Assignee: YUHAN CORPORATIONInventors: Hyun-Joo Lee, Dong-Hoon Kim, Tae-Kyun Kim, Young-Ae Yoon, Jae-Young Sim, Myung-Hun Cha, Eun-Jung Jung, Kyoung-Kyu Ahn, Tai-Au Lee
-
Patent number: 9850227Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: GrantFiled: February 24, 2012Date of Patent: December 26, 2017Assignee: YUHAN CORPORATIONInventors: Hyun-Joo Lee, Dong-Hoon Kim, Tae-Kyun Kim, Young-Ae Yoon, Jae-Young Sim, Myung-Hun Cha, Eun-Jung Jung, Kyoung-Kyu Ahn, Tai-Au Lee
-
Publication number: 20170152241Abstract: The present invention provides: a bicyclic derivative comprising a pyrimidine ring, or a pharmaceutically acceptable salt thereof; a preparation method therefor, a pharmaceutical composition comprising the same; and a use therefor. According to the present invention, the bicyclic compound derivative comprising a pyrimidine ring, or a pharmaceutically acceptable salt thereof acts as a 5-HT4 receptor agonist, and thus can be usefully applied to the prevention or treatment of dysfunction in gastrointestinal motility, for example, gastrointestinal diseases such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, diabetic gastric atony and the like.Type: ApplicationFiled: May 23, 2014Publication date: June 1, 2017Inventors: Jae Young SIM, Myung Hun CHA, Tae Kyun KIM, Young Ae YOON, Dong Hoon KIM
-
Publication number: 20160090374Abstract: The present invention provides: a bicyclic derivative comprising a pyrimidine ring, or a pharmaceutically acceptable salt thereof; a preparation method therefor, a pharmaceutical composition comprising the same; and a use therefor. According to the present invention, the bicyclic compound derivative comprising a pyrimidine ring, or a pharmaceutically acceptable salt thereof acts as a 5-HT4 receptor agonist, and thus can be usefully applied to the prevention or treatment of dysfunction in gastrointestinal motility, for example, gastrointestinal diseases such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, diabetic gastric atony and the like.Type: ApplicationFiled: May 23, 2014Publication date: March 31, 2016Inventors: Jae Young SIM, Myung CHA, Tae Kyun KIM, Young Ae YOON, Dong Hoon KIM
-
Publication number: 20150274700Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: ApplicationFiled: February 24, 2012Publication date: October 1, 2015Applicant: YUHAN CORPORATIONInventors: Hyun-Joo LEE, Dong-Hoon KIM, Tae-Kyun KIM, Young-Ae YOON, Jae-Young SIM, Myung-Hun CHA, Eun-Jung JUNG, Kyoung-Kyu AHN, Tai-Au LEE
-
Publication number: 20130338179Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: ApplicationFiled: February 24, 2012Publication date: December 19, 2013Applicant: YUHAN CORPORATIONInventors: Hyun-Joo Lee, Dong-Hoon Kim, Tae-Kyun Kim, Young-Ae Yoon, Jae-Young Sim, Myung-Hun Cha, Eun-Jung Jung, Kyoung-Kyu Ahn, Tai-Au Lee
-
Publication number: 20130331377Abstract: The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT4 receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.Type: ApplicationFiled: February 24, 2012Publication date: December 12, 2013Applicant: YUHAN CORPORATIONInventors: Hyun-Joo Lee, Dong-Hoon Kim, Tae-Kyun Kim, Young-Ae Yoon, Jae-Young Sim, Myung-Hun Cha, Eun-Jung Jung, Kyoung-Kyu Ahn, Tai-Au Lee
-
Patent number: 8513277Abstract: The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: GrantFiled: November 15, 2011Date of Patent: August 20, 2013Assignee: Yuhan CorporationInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Se-Hoon Keum, Young-Ah Shin, Heui Il Kang, Sun-Young Jang